Koshimichi, H., Retout, S., Cosson, V. F., De Buck, S., Tsuda, Y., Ishibashi, T., & Wajima, T. (2019). 1536. Population Pharmacokinetic Analysis of Baloxavir Morboxil, a Cap-Dependent Endonuclease Inhibitor, in Adult and Adolescent Healthy Subjects and Influenza Patients and Exposure-Response Relationships in the Patients at High-Risk of Influenza Complications. Open Forum Infect Dis.
Chicago Style CitationKoshimichi, Hiroki, Sylvie Retout, Valérie F. Cosson, Stefan De Buck, Yoshiyuki Tsuda, Toru Ishibashi, i Toshihiro Wajima. "1536. Population Pharmacokinetic Analysis of Baloxavir Morboxil, a Cap-Dependent Endonuclease Inhibitor, in Adult and Adolescent Healthy Subjects and Influenza Patients and Exposure-Response Relationships in the Patients At High-Risk of Influenza Complications." Open Forum Infect Dis 2019.
Cita MLAKoshimichi, Hiroki, et al. "1536. Population Pharmacokinetic Analysis of Baloxavir Morboxil, a Cap-Dependent Endonuclease Inhibitor, in Adult and Adolescent Healthy Subjects and Influenza Patients and Exposure-Response Relationships in the Patients At High-Risk of Influenza Complications." Open Forum Infect Dis 2019.